Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 1 1

Status

Unknown 6Recruiting 4Completed 4Withdrawn 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 23Thoracic 4Genitourinary 4Gynecologic 3Head & Neck 2Breast 2Dermatologic 1

Conditions

Prostatic Neoplasms 2Urinary Bladder Neoplasms 1Carcinoma, Renal Cell 1

Interventions

Docetaxel 205Prednisone 151enzalutamide 128Gemcitabine 123Radiotherapy 117Sunitinib 112Cisplatin 103Leuprolide 98pembrolizumab 96Abiraterone Acetate 94bicalutamide 87Nivolumab 85Goserelin 83Sorafenib 80Paclitaxel 79Carboplatin 77Everolimus 72Bevacizumab 71Magnetic Resonance Spectroscopy 66acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 61pazopanib 56radium Ra 223 dichloride 50Ipilimumab 49Zoledronic Acid 47Cyclophosphamide 44Radiosurgery 43Filgrastim 42abiraterone 41gallium 68 PSMA-11 40Surveys and Questionnaires 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Electroporation × Genitourinary × Clear all
NCT04972097 2026-06-02

PRESERVE

Angiodynamics, Inc.

Phase NA Completed
121 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT02335827 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed
15 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT02430623 2021-09-05

IRE

Fuda Cancer Hospital, Guangzhou

Phase NA Completed
30 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT01790451 2015-02-20

Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans

Clinical Research Office of the Endourological Society

Phase 1 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡